Ara City Radio
What's right: new rectal cancer drug shows 100% positive response
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:03:11
- Mas informaciones
Informações:
Sinopsis
The new drug Dostarlimab guides the body's immune system to recognise the cancer cells as harmful and kill them. Patients who followed the six months of treatment showed a complete clinical response with no evidence of tumours during follow-up exams.
